Skip to content

Samantree Medical

Active
Public limited companyfounded 2024active for 2 yearsRue de Bruxelles 174, 4340 Awans, BelgiumKBO/BCE: BE 1010.646.067
Summary

Samantree Medical has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39.1m and a net result of -€5.1m. Its solvency ranks better than 73% of 172 sector peers (NACE 26, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-06-2024 Normal situation
Registered office
38 active companies are registered at this address Source: KBO register, as of 2 November 2026.
Activity
Manufacture of computer, electronic and optical products NACE 26600
Joint committee
200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
Establishment unit
2.361.722.346 4340 Awans, since 23-06-2024
Financial year end
31 December
Peppol
Reachable since 10-12-2025

Board and ownership

Board
and 3 others
Holdings
Shares in 4 companies including SamanTree Medical (Switzerland) SA and SamanTree Medical France

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
-€3.5m
Loss
€5.1m
Equity
€39.1m
Total assets
€53.9m
Employees on 31-12-2025
11
  • €101,458 of overdue social security (RSZ) debts on 31-12-2025
Score breakdownraises riskLoss of €5.1m (financial year 2025)lowers riskSector: Manufacture of computer, electronic and optical products (NACE 26)Size: 5.2 FTE, total assets €53.9mEquity €39.1m (72.4% of total assets)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 49% of micro companies in computer and electronic products (NACE 26)
Financial strength
Average
Solvency 97
equity 72.4% of total assets
Liquidity 56
short-term debt 14.4% · cash 7.3%
Profitability 7
return on assets -9.5%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (447 companies, NACE 26, micro)
Last 24 months 07-2025: 0.8% 08-2025: 0.8%● unchanged vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 0.8%● unchanged vs 09-2025 11-2025: 0.8%● unchanged vs 10-2025 12-2025: 0.9%▲ +0.1 percentage points vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 1.0%▲ +0.1 percentage points vs 01-2026 03-2026: 1.0%● unchanged vs 02-2026 04-2026: 1.0%● unchanged vs 03-2026 05-2026: 1.1%▲ +0.1 percentage points vs 04-2026 06-2026: 1.1%● unchanged vs 05-2026highest value 07-2026: 1.1%● unchanged vs 06-2026highest value 08-2026: 0.5%▼ -0.6 percentage points vs 07-2026 09-2026: 0.5%● unchanged vs 08-2026 10-2026: 0.2%▼ -0.3 percentage points vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value
Credit of up to €3,450,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 2.76, above the usual 1.5. Short-term debt is 14.4% and cash 7.3% of total assets. 27.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 26, micro). It does better than 73% of them on solvency, 51% on liquidity and 23% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Manufacture of computer, electronic and optical products (NACE 26)
KBO
raises risk · Loss of €5.1m (financial year 2025)
NBB · annual accounts
lowers risk · Size: 5.2 FTE, total assets €53.9m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €39.1m (72.4% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
17 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Caution: Lower net result than 91% of companies in computer and electronic productssector median €109,628 · 173 companies -€5.1m View
  • Heads a groupcompanies controlled 4 View

Recent changes

  1. · Gazette deed Capital increase of €60,483.87 to €447,731.76
  2. · Gazette deed Capital & shares · Amendment of the articles
  3. · Gazette deed Appointment: PwC Reviseurs d'Entreprises (statutory auditor)
All 10 events

Comparable companies

These companies have the same main activity as Samantree Medical: manufacture of computer, electronic and optical products (NACE 26600). They are comparable in size and age: total assets between €6.2m and €56m, founded between 1971 and 2023.

CompanyTotal assetsGross margin
Samantree Medical Awans€53.9m-€3.5m
Demant Belgium Leuven€8.8m-
MoveUP Brussel€6.2m€0.9m
Teledyne ICM Dison€9.6m-
Sunrise Namur€43.9m€3.1m
Bruker Belgium Kontich€56.3m-
Full comparison

Key facts about Samantree Medical

What is the company number of Samantree Medical?
The company number of Samantree Medical is 1010.646.067. The VAT number is the same number with BE in front: BE 1010.646.067.
Where is Samantree Medical based?
The registered office is at Rue de Bruxelles 174, 4340 Awans.Company details
What does Samantree Medical do?
According to the KBO register, the main activity is manufacture of computer, electronic and optical products (NACE 26600).
What is the legal form of Samantree Medical?
The legal form of Samantree Medical is Public limited company (NV).
When was Samantree Medical founded?
Samantree Medical was founded on 23-06-2024.
Is Samantree Medical still active?
Yes, Samantree Medical is an active enterprise in the KBO register.
How many employees does Samantree Medical have?
Samantree Medical had an average of 5.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Samantree Medical fall under?
In its 2025 annual accounts, Samantree Medical states joint committee 200 (Aanvullend Paritair Comité voor de bedienden).
What is the turnover of Samantree Medical?
The annual accounts for financial year 2025 state no turnover.
Is Samantree Medical profitable?
In financial year 2025, Samantree Medical made a loss of €5.1m.
Where can I find the annual accounts of Samantree Medical?
Samantree Medical filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.